Haemonetics HAE Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Blood Center | $221.27M+0.2% | $220.86M-5.9% | $234.64M-4.9% | $246.72M-5.5% | $261.12M— | |
| Hospital | $588.3M+2.0% | $576.51M-0.1% | $576.99M+1.2% | $569.91M+1.0% | $564.27M— | |
| Plasma | $524.46M+0.7% | $520.9M+0.9% | $516.22M-2.5% | $529.42M-1.1% | $535.43M— | |
| Operating Income by Business | ||||||
| Blood Center | $49.98M+2.7% | $48.66M-2.6% | $49.95M-1.9% | $50.93M-3.6% | $52.82M— | |
| Hospital | $103.74M+8.1% | $95.96M-1.5% | $97.42M+7.2% | $90.83M+2.1% | $88.98M— | |
| Plasma | $184.8M-3.6% | $191.74M+1.3% | $189.24M-1.0% | $191.07M+3.6% | $184.51M— | |
| Costs incurred, net of reversals by Business | ||||||
| Blood Center | -$558K-1,494% | -$35K+79.7% | -$172K-107% | $2.56M-46.0% | $4.74M-10.5% | |
| Hospital | $1.33M-11.1% | $1.49M-30.7% | $2.15M+10.7% | $1.94M+16.8% | $1.66M-34.0% | |
| Plasma | $448K— | —— | —— | —— | —— | |
| SG&A by Business | ||||||
| Blood Center | $54.13M-2.6% | $55.57M-1.5% | $56.41M-2.9% | $58.1M-3.2% | $60.02M-3.1% | |
| Hospital | $247.25M+1.8% | $242.86M+0.3% | $242.05M-0.3% | $242.89M+0.5% | $241.76M+4.4% | |
| Plasma | $105.32M+2.7% | $102.55M+3.6% | $98.99M-0.5% | $99.49M+1.1% | $98.42M-2.9% | |
| Cost of goods sold by Business | ||||||
| Blood Center | $112.67M+0.8% | $111.78M-9.1% | $122.92M-7.1% | $132.28M-7.2% | $142.51M-7.5% | |
| Hospital | $203.23M+0.1% | $203.05M+0.2% | $202.64M+0.8% | $201.03M+0.8% | $199.5M+6.8% | |
| Plasma | $214.14M+3.4% | $207.07M-0.9% | $208.92M-5.7% | $221.63M-6.5% | $237.05M-7.3% | |
| Total long-lived assets by Business | ||||||
| Blood Center | $158.88M-0.4% | $159.54M— | —— | —— | —— | |
| Hospital | $217.8M+2.8% | $211.96M— | —— | —— | —— | |
| Plasma | $812.2M+2.1% | $795.67M— | —— | —— | —— | |
| R&D by Business | ||||||
| Blood Center | $4.49M-7.6% | $4.86M-9.5% | $5.37M-0.7% | $5.41M-6.3% | $5.77M-9.3% | |
| Hospital | $34.09M-1.6% | $34.65M-0.7% | $34.87M-0.8% | $35.15M+3.3% | $34.04M+6.9% | |
| Plasma | $20.2M+3.4% | $19.55M+2.5% | $19.08M+10.7% | $17.23M+11.5% | $15.45M+5.7% | |
| Restructuring related costs by Business | ||||||
| Blood Center | -$1K-103% | $33K-49.2% | $65K-41.4% | $111K-27.9% | $154K-35.8% | |
| Hospital | $0-100% | $103K+194% | $35K0.0% | $35K-75.5% | $143K+186% | |
| Plasma | $9K-66.7% | $27K-57.8% | $64K-44.3% | $115K-59.1% | $281K-71.8% | |
| D&A by Business | ||||||
| Blood Center | $7.16M-9.2% | $7.89M-8.5% | $8.62M-7.8% | $9.35M-7.2% | $10.08M-7.6% | |
| Hospital | $57.19M0.0% | $57.2M0.0% | $57.22M0.0% | $57.23M0.0% | $57.25M+9.1% | |
| Plasma | $47.37M-0.5% | $47.59M-0.5% | $47.82M-0.5% | $48.04M-0.5% | $48.26M+1.3% | |
| Currency translation by Business | ||||||
| Plasma | $0— | $0— | $0— | $0— | $0— | |
| Goodwill by Business | ||||||
| Blood Center | $108.16M-0.1% | $108.24M-1.6% | $110.01M-5.6% | $116.48M-4.9% | $122.52M-5.1% | |
| Hospital | $2.25B+2.4% | $2.2B+0.2% | $2.2B-0.2% | $2.2B0.0% | $2.2B+2.1% | |
| Plasma | $116.17M0.0% | $116.17M0.0% | $116.17M0.0% | $116.17M0.0% | $116.17M0.0% | |
| Total net revenues by Product | ||||||
| Plasma | $524.46M+0.7% | $520.9M+0.9% | $516.22M-2.5% | $529.42M-1.1% | $535.43M-2.3% | |
| Net revenues by Geography | ||||||
| Europe | $185.02M+6.1% | $174.4M+2.4% | $170.29M+0.6% | $169.31M-3.6% | $175.66M+1.3% | |
| Japan | $68.2M+3.5% | $65.9M+3.1% | $63.94M+2.5% | $62.35M-0.1% | $62.41M+2.6% | |
| Other | $11.42M+3.1% | $11.08M-22.0% | $14.21M-10.0% | $15.79M-19.2% | $19.54M-2.7% | |
| Rest of Asia | $87.21M-1.3% | $88.4M-2.8% | $90.97M-3.4% | $94.17M+2.0% | $92.31M-5.8% | |
| United States | $982.18M+0.4% | $978.5M-1.0% | $988.45M-1.6% | $1B-0.6% | $1.01B+0.6% | |
| Total long-lived assets by Geography | ||||||
| Europe | $112.32M+12.0% | $100.27M— | —— | —— | —— | |
| Japan | $4.38M-7.1% | $4.72M— | —— | —— | —— | |
| Other | $70.99M+0.5% | $70.61M— | —— | —— | —— | |
| Rest of Asia | $123.14M+1.8% | $121.02M— | —— | —— | —— | |
| United States | $878.04M+0.9% | $870.56M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.